Clinical Trials Directory

Trials / Completed

CompletedNCT01201746

Influence of Periodontal Treatment on Systemic Inflammatory Mediators

Influence of Periodontal Treatment on Systemic Inflammatory Mediators:hsC-reactive Protein, Fibrinogen and White Blood Cells in CHD Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
317 (actual)
Sponsor
Sheikh Zayed Federal Postgraduate Medical Institute · Academic / Other
Sex
All
Age
31 Years
Healthy volunteers
Not accepted

Summary

Currently the research issue in establishing the role of periodontal disease (PD) in coronary heart disease (CHD) risk is to define the pathways that lead to cause-effect relationship between PD and CHD. There is no consensus on definition of a periodontal disease case or the threshold level that may give clear indication for this relationship. Periodontal therapy has been used in different studies with the hope that a change in periodontal disease status may modify the factors associated with CHD risk. Many of these studies, on role of periodontal therapy in the reduction of CHD associated risk-factors, were based on small study samples, and very few studies were randomized controlled trials. So a need for large prospective studies is warranted in literature.----------- A single-blind parallel-arm randomized controlled clinical trial was designed to observe the influence of periodontal treatment on serum inflammatory mediators of hsC-reactive protein, white blood cells and fibrinogen in CHD patients. Hypothesis: Periodontal therapy in CHD patients, by reducing periodontal inflammation, may decrease the host systemic inflammatory burden associated with atherogenic processes.

Conditions

Interventions

TypeNameDescription
PROCEDUREDelayed treatmentScaling, Root Planing and oral hygiene instruction
PROCEDUREPeriodontal therapyScaling, root planning and oral hygiene instructions

Timeline

Start date
2008-07-01
Primary completion
2009-04-01
Completion
2009-05-01
First posted
2010-09-15
Last updated
2016-10-14

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT01201746. Inclusion in this directory is not an endorsement.